The Production Linked Incentive Scheme for Medical Devices (PLI-MD) has been extended up to 2035-36, with about Rs 2,700 crore available for fresh applications under 'PLI-MD 2.0'.
Four new target segments, from consumables and implants to high-end devices now only assembled in India, carry tapering incentives averaging about 5% to 9%.
The minimum sales threshold for claiming incentives has been dropped, the minimum investment cut, and the application window kept open continuously.
Since its 2020-21 launch the scheme has brought over 60 high-end devices and components into domestic production, worth over Rs 16,000 crore.
| Aspect | PLI-MD (launched 2020-21) | PLI-MD 2.0 (November 2026) |
|---|---|---|
| Outlay | Rs 3,420 crore | About Rs 2,700 crore available |
| Incentive | 5% of incremental sales over base year 2019-20 | Tapering rate, averaging ~5% (TS1), ~9% (TS2, TS3), 6% (TS4) |
| Segments | Cancer care/radiotherapy; radiology and imaging (incl. nuclear imaging); anaesthetics and cardio-respiratory (incl. catheters); implants (incl. implantable electronic devices) | TS1 consumables, disposables and implants; TS2 critical components; TS3 high-end devices at a nascent stage of domestic manufacturing; TS4 high-end devices presently only assembled in India |
| Sales threshold | Required to claim incentive | Discontinued; minimum investment also trimmed |
| Applications | Fixed rounds | Any number, in one or more segments; window open continuously |
Boost domestic manufacturing and exports under Atmanirbhar Bharat
Key: 14 sectors, total outlay Rs 1.97 lakh crore; covers medical devices, pharma, electronics, telecom, ACC batteries, solar PV modules, drones and others
Grow the domestic medical devices market
Key: Approved by the Union Cabinet in April 2023; target of a USD 50 billion market by 2030, from about USD 11 billion in 2020
Common infrastructure for device makers
Key: Rs 400 crore outlay; up to Rs 100 crore each for four parks in Himachal Pradesh, Tamil Nadu, Madhya Pradesh and Uttar Pradesh (in-principle approval 24 September 2021); assistance covers 90% of project cost in North-Eastern and hilly states, 70% elsewhere
Self-reliance, the policy frame PLI-MD 2.0 cites alongside Make in India
Key: Announced by the PM on 12 May 2020 with a Rs 20 lakh crore package (about 10% of GDP, including earlier measures)
A machine that accelerates electrons along a straight tube and uses them to produce high-energy X-rays, which are aimed at tumours in radiotherapy. LINACs are among the high-end devices PLI-MD has brought into domestic production.
GS Paper 3 > Indian Economy > Industrial Policy
General Awareness > Government Schemes
Incentive paid as a share of incremental sales of goods made in India
Incentive rate that falls year by year over the scheme period
In-vitro diagnostic equipment that tests samples such as blood outside the body